These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 12742983

  • 21. The curative effect comparison of two kinds of therapeutic regimens on decreasing the relative intensity of microembolic signal in CLAIR trial.
    Deng QQ, Tang J, Chen C, Markus H, Huang YN, Zhao H, Ratanakorn D, Wong KS, Fu JH.
    J Neurol Sci; 2016 Aug 15; 367():18-21. PubMed ID: 27423556
    [Abstract] [Full Text] [Related]

  • 22. Glycoprotein IIb/IIIa receptor antagonist tirofiban inhibits thrombin generation during cardiopulmonary bypass in baboons.
    Rao AK, Sun L, Hiramatsu Y, Gorman JH, Edmunds LH.
    Thromb Haemost; 1999 Jul 15; 82(1):140-4. PubMed ID: 10456468
    [Abstract] [Full Text] [Related]

  • 23. FK419, a novel nonpeptide GPIIb/IIIa antagonist, restores microvascular patency and improves outcome in the guinea-pig middle cerebral artery thrombotic occlusion model: comparison with tirofiban.
    Moriguchi A, Maeda M, Mihara K, Aoki T, Matsuoka N, Mutoh S.
    J Cereb Blood Flow Metab; 2005 Jan 15; 25(1):75-86. PubMed ID: 15678114
    [Abstract] [Full Text] [Related]

  • 24. Effect of platelet glycoprotein IIb/IIIa receptor blockade with tirofiban on adverse cardiac events in women with unstable angina/non-ST-elevation myocardial infarction (PRISM-PLUS Study).
    Huynh T, Theroux P, Snapinn S, Wan Y, Montreal General Hospital, Montreal, Quebec, Canada. thao.huynh@muhc.mcgill.ca.
    Am Heart J; 2003 Oct 15; 146(4):668-73. PubMed ID: 14564321
    [Abstract] [Full Text] [Related]

  • 25. Ischemic brain tissue salvaged from infarction by the GP IIb/IIIa platelet antagonist tirofiban.
    Junghans U, Seitz RJ, Ritzl A, Wittsack HJ, Fink GR, Freund HJ, Siebler M.
    Neurology; 2002 Feb 12; 58(3):474-6. PubMed ID: 11839855
    [Abstract] [Full Text] [Related]

  • 26. Prevention of microsurgical anastomotic thrombosis using aspirin, heparin, and the glycoprotein IIb/IIIa inhibitor tirofiban.
    Chung TL, Pumplin DW, Holton LH, Taylor JA, Rodriguez ED, Silverman RP.
    Plast Reconstr Surg; 2007 Oct 12; 120(5):1281-1288. PubMed ID: 17898601
    [Abstract] [Full Text] [Related]

  • 27. Effect of glycoprotein IIb-IIIa receptor antagonism on platelet membrane glycoproteins after coronary stent placement.
    Gawaz M, Ruf A, Neumann FJ, Pogátsa-Murray G, Dickfeld T, Zohlnhöfer D, Schömig A.
    Thromb Haemost; 1998 Dec 12; 80(6):994-1001. PubMed ID: 9869173
    [Abstract] [Full Text] [Related]

  • 28. Does clopidogrel increase the degree of platelet inhibition when a platelet glycoprotein IIb/IIIa inhibitor has been given? Insights from an optical platelet aggregometry study.
    Talreja D, Lubbe D, Orford JL, Lennon R, DiBattiste PM, Berger PB.
    J Thromb Thrombolysis; 2004 Aug 12; 18(1):25-30. PubMed ID: 15744550
    [Abstract] [Full Text] [Related]

  • 29. MK-383 (L-700,462), a selective nonpeptide platelet glycoprotein IIb/IIIa antagonist, is active in man.
    Peerlinck K, De Lepeleire I, Goldberg M, Farrell D, Barrett J, Hand E, Panebianco D, Deckmyn H, Vermylen J, Arnout J.
    Circulation; 1993 Oct 12; 88(4 Pt 1):1512-7. PubMed ID: 8403299
    [Abstract] [Full Text] [Related]

  • 30. [Platelet glycoprotein IIb/IIIa inhibitors in coronary artery disease].
    Auer J, Berent R, Lassnig E, Weber T, Maurer E, Eber B.
    Herz; 2003 Aug 12; 28(5):393-403. PubMed ID: 12928738
    [Abstract] [Full Text] [Related]

  • 31. Effects of glycoprotein IIb/IIIa receptor inhibition with tirofiban on minor myocardial damage in angiographically successful percutaneous coronary angioplasty.
    Okmen E, Sanli A, Uyarel H, Dayi S, Tartan Z, Cam N.
    Cardiology; 2004 Aug 12; 102(1):18-23. PubMed ID: 14988614
    [Abstract] [Full Text] [Related]

  • 32. Glycoprotein IIb/IIIa and P2Y12 receptor antagonists yield additive inhibition of platelet aggregation, granule secretion, soluble CD40L release and procoagulant responses.
    Judge HM, Buckland RJ, Holgate CE, Storey RF.
    Platelets; 2005 Nov 12; 16(7):398-407. PubMed ID: 16236601
    [Abstract] [Full Text] [Related]

  • 33. Clopidogrel load for emboli reduction in patients with symptomatic carotid stenosis undergoing urgent carotid endarterectomy.
    Tsivgoulis G, Kerasnoudis A, Krogias C, Vadikolias K, Meves SH, Heliopoulos I, Georgakarakos E, Piperidou C, Alexandrov AV.
    Stroke; 2012 Jul 12; 43(7):1957-60. PubMed ID: 22556193
    [Abstract] [Full Text] [Related]

  • 34. Antiplatelet therapy with glycoprotein IIb/IIIa receptor inhibitors and other novel agents.
    Schafer AI.
    Tex Heart Inst J; 1997 Jul 12; 24(2):90-6. PubMed ID: 9205981
    [Abstract] [Full Text] [Related]

  • 35. Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization.
    Topol EJ, Moliterno DJ, Herrmann HC, Powers ER, Grines CL, Cohen DJ, Cohen EA, Bertrand M, Neumann FJ, Stone GW, DiBattiste PM, Demopoulos L, TARGET Investigators. Do Tirofiban and ReoPro Give Similar Efficacy Trial.
    N Engl J Med; 2001 Jun 21; 344(25):1888-94. PubMed ID: 11419425
    [Abstract] [Full Text] [Related]

  • 36. Safety evaluation of tirofiban.
    Valgimigli M, Tebaldi M.
    Expert Opin Drug Saf; 2010 Sep 21; 9(5):801-19. PubMed ID: 20670206
    [Abstract] [Full Text] [Related]

  • 37. Assessment of 'on-treatment platelet reactivity' and relationship with cerebral micro-embolic signals in asymptomatic and symptomatic carotid stenosis.
    Kinsella JA, Oliver Tobin W, Tierney S, Feeley TM, Egan B, Coughlan T, Ronan Collins D, O'Neill D, Harbison JA, Doherty CP, Madhavan P, Moore DJ, O'Neill SM, Colgan MP, Saqqur M, Murphy RP, Moran N, Hamilton G, McCabe DJH.
    J Neurol Sci; 2017 May 15; 376():133-139. PubMed ID: 28431600
    [Abstract] [Full Text] [Related]

  • 38. Timing of coronary stent thrombosis in patients treated with prophylactic tirofiban.
    Assali AR, Sdringola S, Ghani M, Westbrook LA, Anderson HV, Schroth G, Fujise K, Smalling RW, Rosales OR.
    J Invasive Cardiol; 2000 Sep 15; 12(9):460-3. PubMed ID: 10973371
    [Abstract] [Full Text] [Related]

  • 39. Increased reperfusion by glycoprotein IIb/IIIa receptor antagonist administration in case of unsuccessful and failed thrombolysis in patients with acute myocardial infarction: a pilot study.
    Di Pasquale P, Sarullo FM, Cannizzaro S, Vitrano MG, Giubilato A, Scalzo S, Giambanco F, Paterna S.
    Ital Heart J; 2001 Oct 15; 2(10):751-6. PubMed ID: 11721719
    [Abstract] [Full Text] [Related]

  • 40. [The clinical use of the GPIIb/IIIa inhibitors eptifibatide and tirofiban in the treatment of acute coronary syndromes of the "non-ST elevation" type].
    Galli M, Maggioni AP, Vassanelli C, Tavazzi L.
    Ital Heart J Suppl; 2000 Feb 15; 1(2):202-11. PubMed ID: 10731377
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.